Trump Set to Ease Restrictions on Psychedelic Drug for PTSD
Psychedelic drug policy developments are shaping the future of PTSD treatment. Regulatory easing could improve patient access to FDA-approved therapies. Clinicians should monitor these changes closely for clinical implications.
Trump Plans Psychedelic Executive Order (Newsletter: April 17, 2026)
The 2026 psychedelic drug policy developments could reshape access to psilocybin and MDMA treatments currently in FDA trials. These changes matter clinically for patients with PTSD and depression. Clinicians should monitor these developments closely for…
Many will judge me, but cannabis controls my anxiety
Cannabis clinical stigma remains a barrier despite many patients using it to control anxiety. This article highlights personal experiences and clinical insights into cannabis for anxiety. Understanding stigma helps improve patient access and informed…
High-Potency Cannabis: America’s New Pastime and Psychiatry’s Next Challenge
High-potency THC products dominate the US cannabis market, posing new challenges for psychiatry. These products require updated dosing guidelines and harm reduction strategies. Understanding high-potency THC products is essential for clinical assessment…
Can CBD Gummies Make You Depressed? Insights from Pathologica
CBD depression drug safety dosing is a critical topic for clinicians and patients alike. Current evidence shows mixed effects of CBD on mood, requiring careful monitoring. Understanding dosing and product quality is essential to avoid worsening…
Tennessee Lawmakers Vote To Block Potential State Medical Marijuana Legalization After Federal Rescheduling
Tennessee medical marijuana legislation has recently blocked potential legalization despite federal rescheduling efforts. This state-level prohibition limits patient access to cannabis therapies. Clinicians must navigate these restrictions while staying…
Addiction Policy Forum Launches Cannabis Use Disorder Prevention and Awareness Week
Cannabis use disorder prevention strategies are critical as cannabis use rises. The Addiction Policy Forum has launched an awareness week to promote these strategies. Early identification and intervention can reduce the impact of cannabis use disorder.
Frequent Social Media Use Linked to Cannabis Use in Adolescents
Recent research highlights adolescent cannabis use and social media as strongly linked factors. Frequent social media use may increase cannabis initiation risk among youth. Clinicians should screen for both to guide prevention and counseling.
Myth Masquerading as Science: CU Anschutz Addiction Psychiatrist Investigates Cannabis Brain Development Risks
This article examines cannabis brain development risks, challenging the myth that brain maturation continues until age 25. CU Anschutz addiction psychiatrist Dr. Bryon Adinoff reviews the evidence and finds limited support for this claim. Understanding…
Review Finds Limited Evidence for Cannabis in Treating Mental Health Disorders
A recent review highlights limited evidence cannabis mental health benefits for conditions like PTSD and anxiety. The study emphasizes the need for more rigorous research. Clinicians should consider cannabis as adjunctive, not primary, therapy.